A phase I clinical study to assess safety and immunogenicity of yellow fever vaccine

A phase I clinical study to assess safety and immunogenicity of yellow fever vaccine

Abstract Yellow fever, a mosquito-borne flavivirus infection, is an important public health problem in Africa and Latin America. A Yellow Fever vaccine (YFV) was developed and tested in a study in India. This was a Phase I, open-label, randomized, controlled study where healthy adults received SII Y...

ver descrição completa

Detalhes bibliográficos
Principais autores: Sajjad Desai, K. Anil, Anirudha Vyankatesh Potey, Y. Sindhu, Silvia Grappi, Giulia Lapini, Satyaprasad Manney, Parikshit Tyagi, Emanuele Montomoli, Cyrus S. Poonawalla, Prasad S. Kulkarni
Formato: Artigo
Idioma:English
Publicado em: Nature Portfolio 2022-12-01
coleção:npj Vaccines
Acesso em linha:https://doi.org/10.1038/s41541-022-00595-6

Registros relacionados

Registros relacionados